177lu-psma-617,olaparib
novartis,merck,astrazeneca
['luparp', 'pcsm']
4) continue to explore how parpi can sensitize when combined with other therapeutic modalities such as rlt - luparp trial #pcsm #asco23 #asco2023 - 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.